Tech Company Financing Transactions

Aptinyx Funding Round

On 5/11/2016, Aptinyx raised $65 million in Series A funding from New Leaf Venture Partners, Adams Street Partners and Frazier Healthcare Partners.

Transaction Overview

Company Name
Aptinyx
Announced On
5/11/2016
Transaction Type
Venture Equity
Amount
$65,000,000
Round
Series A
Investors

New Leaf Venture Partners (Lead Investor) (Liam Ratcliffe)

Adams Street Partners

Frazier Healthcare Partners (James Topper)

Longitude Capital Management (Patrick Enright)

Northwestern University

Osage Partners

PathoCapital

Proceeds Purpose
The funds will support initial clinical studies for Aptinyx's lead drug candidate and discovery of additional small-molecule modulators of the NMDA receptor.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
909 Davis St. 600
Evanston, IL 60201
USA
Phone
(847) 871-0377
Website
www.aptinyx.com
Email Address
[email protected]
Overview
Aptinyx Inc. is a biopharmaceutical company discovering and developing innovative therapies for challenging disorders of the brain and nervous system.
Profile
Aptinyx LinkedIn Company Profile
Social Media
Aptinyx Company Twitter Account
Company News
Aptinyx News
Facebook
Aptinyx on Facebook
YouTube
Aptinyx on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Norbert Riedel
  Norbert Riedel LinkedIn Profile  Norbert Riedel Twitter Account  Norbert Riedel News  Norbert Riedel on Facebook
Chief Operating Officer
Ashish Khanna
  Ashish Khanna LinkedIn Profile  Ashish Khanna Twitter Account  Ashish Khanna News  Ashish Khanna on Facebook
Chief Scientific Officer
Joseph Moskal
  Joseph Moskal LinkedIn Profile  Joseph Moskal Twitter Account  Joseph Moskal News  Joseph Moskal on Facebook
VP - Human Resources
Patricia Adams
  Patricia Adams LinkedIn Profile  Patricia Adams Twitter Account  Patricia Adams News  Patricia Adams on Facebook
VP - R & D
Cassia Cearley
  Cassia Cearley LinkedIn Profile  Cassia Cearley Twitter Account  Cassia Cearley News  Cassia Cearley on Facebook
VP - R & D
Amin Khan
  Amin Khan LinkedIn Profile  Amin Khan Twitter Account  Amin Khan News  Amin Khan on Facebook

 

 

Browse more venture capital transactions:

Prev: 5/11/2016: Outbrain venture capital transaction
Next: 5/11/2016: SPIDR venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to report on funding rounds that are announced publicly. All VC database entries reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.